The related press release highlights some of the key changes made to the guideline, including:
• A lower target HbA1c of 48 mmol/mol (6.5%) or lower
• A new recommendation that all adults with type 1 diabetes be offered a structured education programme of proven benefit (e.g. DAFNE)
• The insulin regimen of choice is now multiple daily injection basal–bolus insulin regimens, rather than twice-daily mixed insulin regimens